Baillie Gifford & Co. Purchases 9,618 Shares of Schrödinger, Inc. (NASDAQ:SDGR)

Baillie Gifford & Co. lifted its position in Schrödinger, Inc. (NASDAQ:SDGR) by 0.4% in the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 2,612,007 shares of the company’s stock after purchasing an additional 9,618 shares during the quarter. Baillie Gifford & Co. owned 3.61% of Schrödinger worth $70,524,000 at the end of the most recent reporting period.

Several other hedge funds have also recently added to or reduced their stakes in SDGR. International Assets Investment Management LLC boosted its stake in shares of Schrödinger by 3,480.0% in the 4th quarter. International Assets Investment Management LLC now owns 1,790 shares of the company’s stock valued at $64,000 after purchasing an additional 1,740 shares in the last quarter. GAMMA Investing LLC acquired a new position in shares of Schrödinger in the 4th quarter worth approximately $67,000. PNC Financial Services Group Inc. increased its stake in shares of Schrödinger by 186.7% in the fourth quarter. PNC Financial Services Group Inc. now owns 2,127 shares of the company’s stock valued at $76,000 after buying an additional 1,385 shares in the last quarter. Exchange Traded Concepts LLC increased its holdings in shares of Schrödinger by 34.0% in the fourth quarter. Exchange Traded Concepts LLC now owns 4,244 shares of the company’s stock valued at $152,000 after purchasing an additional 1,076 shares in the last quarter. Finally, Quest Partners LLC bought a new stake in shares of Schrödinger during the fourth quarter worth $153,000. Institutional investors and hedge funds own 79.05% of the company’s stock.

Schrödinger Trading Up 3.0 %

SDGR stock traded up $0.61 during mid-day trading on Friday, hitting $20.71. The stock had a trading volume of 421,040 shares, compared to its average volume of 668,364. Schrödinger, Inc. has a 52 week low of $18.21 and a 52 week high of $59.24. The firm has a market capitalization of $1.51 billion, a P/E ratio of -11.02 and a beta of 1.51. The firm has a fifty day simple moving average of $21.65 and a 200 day simple moving average of $26.01.

Schrödinger (NASDAQ:SDGR) last released its earnings results on Wednesday, May 1st. The company reported ($0.76) earnings per share (EPS) for the quarter, meeting analysts’ consensus estimates of ($0.76). Schrödinger had a negative return on equity of 29.25% and a negative net margin of 75.94%. The firm had revenue of $36.60 million for the quarter, compared to analysts’ expectations of $41.23 million. As a group, equities analysts expect that Schrödinger, Inc. will post -2.83 earnings per share for the current fiscal year.

Wall Street Analyst Weigh In

A number of equities analysts have issued reports on SDGR shares. Citigroup reduced their target price on Schrödinger from $39.00 to $37.00 and set a “buy” rating on the stock in a report on Thursday, May 2nd. SVB Leerink started coverage on shares of Schrödinger in a report on Tuesday. They set an “outperform” rating and a $29.00 target price on the stock. Leerink Partnrs raised Schrödinger to a “strong-buy” rating in a research note on Tuesday. Finally, Craig Hallum cut their target price on Schrödinger from $35.00 to $30.00 and set a “buy” rating on the stock in a research note on Thursday, May 2nd. Three equities research analysts have rated the stock with a hold rating, seven have issued a buy rating and one has issued a strong buy rating to the stock. Based on data from MarketBeat, Schrödinger currently has a consensus rating of “Moderate Buy” and an average target price of $39.70.

Schrödinger Profile

Schrödinger, Inc, together with its subsidiaries, develops physics-based computational platform that enables discovery of novel molecules for drug development and materials applications. The company operates in two segments, Software and Drug Discovery. The Software segment is focused on licensing its software to transform molecular discovery for life sciences and materials science industries.